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Abstract
Background: Osteoinductive bone substitutes are defined by their ability to induce new bone formation even at
heterotopic implantation sites. The present study was designed to analyze the potential osteoinductivity of two
different bone substitute materials in caprine muscle tissue.
Materials and methods: One gram each of either a porous beta-tricalcium phosphate (β-TCP) or an
hydroxyapatite/silicon dioxide (HA/SiO2)-based nanocrystalline bone substitute material was implanted in several
muscle pouches of goats. The biomaterials were explanted at 29, 91 and 181 days after implantation. Conventional
histology and special histochemical stains were performed to detect osteoblast precursor cells as well as
mineralized and unmineralized bone matrix.
Results: Both materials underwent cellular degradation in which tartrate-resistant acid phosphatase (TRAP)-positive
osteoclast-like cells and TRAP-negative multinucleated giant cells were involved. The ß-TCP was completely
resorbed within the observation period, whereas some granules of the HA-groups were still detectable after 180
days. Neither osteoblasts, osteoblast precursor cells nor extracellular bone matrix were found within the
implantation bed of any of the analyzed biomaterials at any of the observed time points.
Conclusions: This study showed that ß-TCP underwent a faster degradation than the HA-based material. The lack
of osteoinductivity for both materials might be due to their granular shape, as osteoinductivity in goat muscle has
been mainly attributed to cylindrical or disc-shaped bone substitute materials. This hypothesis however requires
further investigation to systematically analyze various materials with comparable characteristics in the same
experimental setting.
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The search continues for an “ideal” bone substitute for
the support, augmentation or replacement of bony tissue
defects. Among other properties, these bone substitutes
should ideally possess osteoconductivity, osteoinductivity
and osteogenicity. Despite the increase in the number of
surgical procedures that require bone grafts, there is still
no ideal bone graft substitute [1]. Although autografts
are the gold standard that all other alternatives must
meet or exceed, they have significant limitations, includ-
ing donor site morbidity, inadequate tissue quantity, in-
appropriate forms [2,3] and sometimes the need for
general anesthesia for their harvest [4,5]. These limita-
tions have prompted increasing interest in alternative
bone grafts. Allografts may be cancellous, cortical or a
combination of these. Though they are attractive sources,
several problems arise when using them, including the risk
of disease transmission, immunogenicity [6] loss of bio-
logical and mechanical properties secondary to processing,
increased cost, and lack of availability due to financial and
religious-cultural concerns [1].
The drawbacks associated with natural bone grafts
have led to the production of a large number of syn-
thetic grafts. The latter are readily available, do not
cause an antigenic response and can easily be tailored to
the intended application. However, the biological per-
formance of synthetic bone grafts in terms of initiation
and support of bone growth is inferior to natural bone
grafts [7]. Their biological behaviour depends upon their
chemical composition and physicochemical structure.
4 A
group of these synthetic biomaterials are termed osteoin-
ductive biomaterials. These materials are potentially “in-
telligent” bone graft substitutes in that they are able to
induce the in vivo environment to form bone [7]. This also
refers to their ability to stimulate and support the prolif-
eration and differentiation of mesenchymal progenitor
cells of the host tissue [8] when implanted in ectopic
(i.e., extraskeletal) sites, together with the induction of
bone formation [9,10]. Although the exact process of
osteoinduction by biomaterials is still largely unknown,
studies have shown that biomaterials need to meet very
specific requirements in terms of macrostructure, micro-
structure and chemical composition in order to be osteoin-
ductive [7,11].
The osteoinductive potential of NanoBone
W (NB) hy-
droxyapatite/silicon dioxide (HA/SiO2)-based nanocrystal-
line bone substitute has been demonstrated in an in vivo
study in mini pigs by Götz et al. [12]. The authors
reported both new bone formation and osteogenic differ-
entiation which they claimed were better in the subcuta-
neous tissue than in the intramuscular implantation sites.
Our group has also been able to demonstrate in clinical
trials the cellular pathway involved in NB degradation [13]
and its osteoconductive capacity to promote sufficient
new bone formation required for stable implant placement
after three months [14].
The main aim of the present study was to investigate the
osteoinductive potential of NB granules in goat intramus-
cular implantation sites in comparison with Cerasorb
W a
pure-phase beta tricalciumphosphate (ß-TCP) granules.
Materials and methods
Bone grafting substitute NanoBone
W
NanoBone
W (Artoss, Rostock, Germany), a fully syn-
thetic bone substitute granule, consists of hydroxyapatite
crystallites with an average size of 60 nm in each crystal-
lographic direction that are embedded in a matrix of silica
gel. It is produced by a sol–gel-technique at temperatures
below 700°C, avoiding sintering of the nanocrystalline hy-
droxyapatite [15]. In the transition process from sol to gel,
a loose connection of hydroxyapatite crystals with the
SiO2 molecules takes place. This connection is responsible
for a nanoporous structured bone substitute. The bioma-
terial is characterized by numerous open bonds, which are
responsible for an internal surface of up to 84 m
2/g in size.
The pore size distribution within the silica gel ranges from
10 to 20 nm in diameter. Macroscopically, the fir cone-
shaped NanoBone
W granules possess an average length of
2 mm and an average diameter of 0.6 mm with a porosity
of 60% - 80%.
Bone grafting substitute cerasorb
W
The details of the synthesis of pure phase β-TCP and the
fabrication of Cerasorb
W M (Curasan, Kleinostheim,
Germany) are described elsewhere [16]. Briefly, pure
phase β-tricalcium phosphate was synthesized by a
solid-state reaction. After crushing and sieving a portion
(< 63 μm) of the generated material, the ceramic parti-
cles were mixed with an organic porogen and pressed to
rods. During a second sintering step (≥ 1000°C) the
porogen disappeared. The resulting ceramic was highly
porous with macropores of about 50–500 μm intercon-
nected by micropores. After crushing the porous rods to
splint granulates, the desired granulate sizes were
reached by sieving. Finally Cerasorb
W M was sterilized
by gamma irradiation.
Experimental design of the muscle model in goats
This study was performed in an accredited laboratory
(RCC Ltd, Zelgliweg 1, 4452 Itlingen/Schwitzerland) in
accordance with the Swiss Animal Protection Law under
license (no. BL338) and by following internationally
recognised guidelines. Six female goats (Capra hircus,
Olsberg, Switzerland) were kept in agricultural animal
husbandry in group housing of 100 square meters for six
animals. Straw bedding was provided. Standard goat
maintenance diet (Landi Jungfrau AG, Switzerland) was
presented twice daily with water ad libitum. The animals
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the following time points: 28, 91 and 181 days.
Bone induction in ectopic tissue was analyzed by
implanting the biomaterial in muscle pouches of the
right Musculus longissimus dorsi (M. long. dorsi) and
Musculus biceps femoris (M. biceps femoris). In each
animal, one muscle pouch was operated without bioma-
terial implantation for the above mentioned time points
(sham operation). These empty muscle pouches were
used to classify the inflammatory response related to the
operation in the absence of biomaterial implantation.
After medication with propofol at a dose sufficient to en-
sure appropriate induction of anesthesia (5–7m g / k gi . v . ) ,
the level of anesthesia was maintained by means of isoflur-
ane/oxygen via face-mask. Prior to surgery, the respective
sites were shaved and disinfected with a standard of iod-
ine/povidone (Betadine
W) solution. Four to five muscle
pouches per animal, either in the M. longissimus dorsi or
M. biceps femoris, were formed after skin incision and
blunt preparation with surgical scissors of approximately
0.5 cm diameter. A small amount of the biomaterial, i.e.
1.0 g, was deployed using glass-weighing boats with spouts
for reliable positioning of the granular material in the
muscle pouches. The muscle pouches were then closed
with a button seam, likewise the following layers and the
skin. All work was performed under sterile conditions.
Postoperative analgesia consisted of single intramuscular
injections of Metamizol at doses of 20 mg/kg body weight.
During the acclimatization and post-surgical observation
periods, the animals were only transiently separated for the
assessment of clinical signs and body weights.
Tissue preparation and histology for the muscle model
The animals were anesthetized with a captive bolt pistol
and sacrificed by exsanguination. Immediately after death,
the implantation beds containing the biomaterials were
explanted together with the surrounding muscle pouches
and fixed in 4% formalin for 24 hours for further histo-
logical and immunohistochemical analysis. The implant
sites of each of the six animals were cut into three seg-
ments of identical dimensions of 4 mm thickness according
to previously described methods.
16 The central segment of
the intramuscular pocket containing the biomaterial was
used to identify osteoclast-like cells by staining for
tartrate-resistant acid phosphatase (TRAP) and for the
identification of osteoid and/or bone matrix by Movat´s
pentachrome and Sirius red staining according to previ-
ously described methods [13,17,18].
Results
Histological results in goat muscle
The tissue reactions to the granules in goat muscles
were varied and are highlighted under separate headings
below.
Tissue reaction to nanocrystalline hydroxyapatite
granules
Within the implantation bed of the nanocrystalline hy-
droxyapatite, the surface of the granules was surrounded by
multinucleated giant cells. The degradation of the bioma-
terial was initiated from the periphery of the material and
continued for the duration of the study (Figure 1A-C). Ac-
cordingly, the size of the granules decreased from day 29
until day 181 after implantation (Figure 1A-C). The multi-
nucleated giant cells within the implantation bed of this
bone substitute were mostly TRAP-negative. However, a
few TRAP-positive multinucleated giant cells were also
located on the surface of the HA-based material
(Figure 2A). At day 91, the HA granules were well inte-
grated within the implantation bed. At day 181 after im-
plantation, the granules were penetrated by fibrous tissue
and phagocytic cells resulting in their breakdown and
disintegration (Figure 2C). At no time within the obser-
vational period osteoblasts or bone-specific matrix could
be identified via immunohistochemical staining methods
in any implantation bed of this nanocrystalline bone
substitute.
Tissue reaction to the β-TCP granules
Within the implantation bed of the β-TCP-based bone
substitute, all granules were well integrated. As early as
day 28 after implantation, connective tissue fibers as well
as phagocytic cells, such as macrophages and multinu-
cleated giant cells, penetrated the center of the granules.
Also at this time point, a progressive degradation of the
material was visible, and small particles of the granules
were incorporated into multinucleated giant cells
(Figure 1D). The β-TCP-based granules were almost
completely degraded at day 91 after implantation
(Figure 1E). At this time point, the major part of the
implantation bed was invaded by multinucleated giant
cells, which contained small components of the gran-
ules within their cytosol. At day 181 after implant-
ation, the β-TCP-based bone substitute material was
totally degraded and only collagenous fibrous tissue
with a few vessels remained (Figure 1F). Within the
implantation bed, TRAP-positive multinucleated giant
cells that were involved in the degradation of the bioma-
terial could be found. However, their number seemed to
be higher within the implantation bed of the β-TCP-based
bone substitute when compared with the implantation
bed of the nanocrystalline material (Figure 2B). Neither
osteoblasts nor bone-specific matrix was found in any of
the implantation beds of this β-TCP-based bone substitute
at any time point.
Discussion
The present study demonstrated that the two bone substi-
tute materials showed differences in the extent of
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points of the study (day 28–181). A-C) display the tissue reaction to the HA-based nanocrystalline biomaterial on day 28 (A), day 91 (B) and
day 181 (C) after implantation respectively. Note the osteoclast-like giant cells (GC) in close contact with the material (HA) on day 28 and day 91,
with no sign of biomaterial breakdown (A: H&E-staining, 100x magnification, scale bar = 10 μm, B: H&E-staining, 200x magnification, scale bar =
10 μm), CT=connective tissue). On day 181 (C) a breakdown of granule integrity by fibrous tissue and phagocytic cells is observed, which resulted
in many small particles within the implantation bed (Masson-Goldner-staining, 100x magnification, scale bar = 10 μm). D-F) show the tissue
reaction to the β-TCP-based material on day 28 (D), day 91 (E) and day 181 (F). On day 28 the material (TCP) is surrounded and invaded by many
multinucleated giant cells (GC) (H&E-staining, 200x magnification, scale bar = 10 μm). On day 91 only few remnants of the biomaterial can be
detected, while osteoclast-like giant cells (GC) dominate the implant side. Fragments of the bone substitute are detectable in the cytoplasm of
the multinucleated giant cells (dashed line) (H&E-staining, 400x magnification, scale bar = 10 μm. On day 181 fibrous tissue remains after the fast
degradation of the biomaterial (H&E-staining, 100x magnification, scale bar = 10 μm).
Figure 2 Shows comparative TRAP-staining of the HA-based (A) and the β-TCP-based (B) bone substitutes. The HA-based material only
induces the formation of multinucleated giant cells (GC) with few nuclei on its surface, while the β-TCP-based material induces the fusion of
voluminous multinucleated giant cells that contain particles of the biomaterial within their cytoplasm (dashed line) (A+B: TRAP-staining, 400x
magnification).
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ation beds. Multinucleated giant cells in the implant-
ation bed of the β-TCP-based bone substitute were
mostly TRAP-positive, whereas only a few TRAP-
positive giant cells were located on the surface of NB.
The higher presence of multinucleated giant cells, es-
pecially the TRAP-positive subpopulation within the
implantation bed of β-TCP, reflects the influence of the
chemical composition of this bone substitute on the
expression of the degrading enzyme tartrate-resistant
acid phosphatase [19,20]. Accordingly, the high pres-
ence of multinucleated giant cells might be related to
the composition of the used β-TCP and might be, in
addition to dissolution, a reason for its comparably fas-
ter degradation [19,20]. Multinucleated giant cells are
known to originate from mononuclear phagocytic cells
such as macrophages [21-23] and their presence reflects
the foreign body reaction, which is described for such bio-
materials [13,20,24]. Thus, gene expression of degrading
enzymes like TRAP is dependent on the characteristics of
the biomaterial [21,22,25].
The degradation pattern which was observed for NB
in this study is similar to what our group had previously
reported following material implantation in subcutane-
ous tissue of Wistar rats [24]. This material underwent a
more continuous degradation over time, and the break-
down of the granules into particles took place at later
stages of the study.
The control over the degradation rate of a biomaterial
is an essential aspect for its contribution to bone remod-
eling. Studies investigating the osteoinductive properties
of macroporous calcium phosphate cements postulated
that fast biomaterial degradation may have a negative in-
fluence on its osteoinductive characteristics [26]. Thus, a
fast degradation will result in a connective tissue influx,
which might inhibit bone regeneration in the respective
defect [26]. However, it remains unclear to what extent
this connective tissue influx into a bone defect as a result
of biomaterial degradation might undergo differentiation
into bone over time. Therefore, the activity of degrading
cells could be controlled by the physicochemical charac-
teristics of the material, as shown by the two analyzed
materials.
In this study, we have studied the potential osteoin-
ductivity of the two bone substitute materials by means
of histological and histochemical staining methods.
Throughout the study period, no osteoblasts or bone-
specific matrices could be found in any implantation bed
of the used NB granules. These data are in accordance
with previous studies, which also failed to show osteoin-
ductive properties of HA-based bone substitutes within
goat muscle when compared to various forms of porous
biphasic calcium phosphates (BCP) [11]. However, it must
be mentioned that the other authors used cylindrically-
shaped calcium phosphate ceramics [11] and not granules
as in the present study. Despite the presence of micro-
and nanopores, NB in its granular form within caprine
muscle probably did not induce sufficient mineral ion
influx and protein-related surface modifications, which
are suggested as a requirement to trigger osteoinduc-
tion [27-29]. On the other hand, another in vivo study
in mini pigs reported a marked osteoinduction within
subcutaneous as well as muscle implantation sites
induced by the very same NB-granules [12]. Thus, we
assume that the lack of osteoinductivity of NB in the
present study could be explained on the basis of its ap-
plication form, i.e. granules and the animal species.
It is noteworthy that β-TCP granules, which were used
as controls in the present study, stimulated neither
osteoblasts nor bone-specific matrices in any of the im-
plantation beds throughout the observational period.
The failure of β-TCP to induce ectopic bone formation
when applied as a single bone substitute material has
also been previously described [30]. In combination with
bone marrow stromal cells [31], however, and along with
hydroxyapatite as biphasic calcium phosphate ceramics
[32-34], it has been shown to induce different degrees of
osteoinductivity, even in ectopic tissues. With regard to
objectivity, it has to be considered whether the used ß-TCP
granules would have shown some osteoinductive proper-
ties, when implanted into the subcutaneous or muscle tis-
sue of the mini-pig as was done for NB [12]. Furthermore,
it has to be emphasized that for ß-TCP, osteoinduction has
been demonstrated in dogs [35,36]. However, the materials
used for the dog study were of different morphology,
namely either cylindrical or disc shape.
The reasons for lack of ectopic bone formation in the
present study are not apparent. Despite the fact that the
principle behind the process of osteoinduction is largely
unknown, it is believed to be positively influenced by the
chemical composition of biomaterials [37], their sinter-
ing temperature [38], material dissolution [37], macro-
and microporosity [36-38], implant size and the applied
animal model [34,39]. Besides these factors, inflamma-
tion itself might be an influencing factor for bone induc-
tion. The release of cytokines, which consequently lead
to a higher circulation within the implantation bed,
stimulate circulating stem cells to differentiate into
osteoblastic cells [34]. Accordingly, a better understand-
ing of the degradation-related inflammatory response
may contribute to better tailoring of bone substitute
materials.
Based on the results of this study and the available lit-
erature, it is evident that ectopic bone formation is
highly influenced by the chosen animal model, i.e. sub-
cutaneous vs. intramuscular implantation sites, species,
for example, goat vs. monkey, dog, mini-pig and sheep,
as well as morphology, i.e. porous granules vs. solid
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The granular form seems to be an influential parameter
to a higher extent than previously assumed. These differ-
ences might be the reason why the implantation of the
NB-granules led to ectopic bone formation in the sub-
cutaneous and the muscle tissue of mini-pigs [12], while
no osteoinductive capacity was observed when the same
granules were implanted into caprine muscle.
These findings notwithstanding, our group and other
groups have been able to show appreciable success with
the clinical application of both bone substitute materials
used here [13,14,40-42]. Despite their potential lack of
de novo bone formation in an ectopic large animal
model, they are still very relevant as viable alternatives
to autografts as the search for the “ideal” bone substitute
continues. The present study demonstrates that success
nor failure of ectopic bone formation induced by bioma-
terials should not be over interpreted. The primary focus
should be placed on the clinical outcome e.g. implant-
ation and on the adaptation of the applied materials to
the patient’s individual needs.
Conclusion
The present study showed that ß-TCP granules induced
more TRAP-positive multinucleated giant cell inflamma-
tory reaction compared to NB granules. Consequently,
the former underwent faster degradation. It has to be
elucidated, whether the detected multinucleated giant
cells within the implantation bed of the used materials
are foreign body giant cells or osteoclasts. The former
are involved in foreign body reactions, while the latter
are known to induce the differentiation of mesenchymal
stem cells into osteoblasts. The understanding of the
molecular mechanism of the multinucleated giant cells
involved in calcium phosphate ceramic degradation is of
high relevance, especially since this knowledge might
help to understand the interaction of inflammation and
osteoinduction. Neither osteoblasts nor newly formed
bone were detected in any of the implantation beds of
the two materials at any time point during the study.
The lack of osteoinduction observed here especially in
the case of NB might be a result of its application form,
i.e. granules and the animal model used. Osteoinduction
was previously reported in goat muscle tissue related to
cylindrical or disc-shaped calcium phosphate ceramics
and not granules. On the other hand it has been docu-
mented that osteoinduction occurred for NB in granular
form in the muscle tissue of mini-pigs. Accordingly, the
question arises which material characteristics and which
micro-environment are required to induce osteoinduc-
tion in calcium phosphate ceramic granules. It should
however be noted that the lack of osteoinductivity in ec-
topic tissue in an animal model does not necessarily pre-
dict the potential of these materials to induce de novo
bone formation in humans. Indeed clinically, the two
materials investigated in this study have proven to be
suitable for human bone regeneration.
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